Bill Text: TX SB315 | 2025-2026 | 89th Legislature | Comm Sub
Bill Title: Relating to a property right in DNA; providing injunctive relief and a civil penalty; creating a criminal offense.
Sponsorship: Partisan Bill (Republican 3)
Status: (Engrossed - Dead) 2025-05-27 - Placed on General State Calendar [SB315 Detail]
Download: Texas-2025-SB315-Comm_Sub.html
| 89R31067 RAL-D | ||
| By: Kolkhorst, et al. | S.B. No. 315 | |
| (Harris Davila) | ||
| Substitute the following for S.B. No. 315: No. | ||
|
|
||
|
|
||
| relating to a property right in DNA; providing injunctive relief | ||
| and a civil penalty; creating a criminal offense. | ||
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
| SECTION 1. Title 1, Property Code, is amended by adding | ||
| Chapter 3 to read as follows: | ||
| CHAPTER 3. PROPERTY RIGHT IN DNA | ||
| Sec. 3.001. DEFINITIONS. In this chapter: | ||
| (1) "DNA" means deoxyribonucleic acid. | ||
| (2) "DNA sample" means a blood sample or other | ||
| biological sample or specimen provided by an individual for the | ||
| purpose of conducting DNA analysis or storage. | ||
| (3) "Genetic characteristic" means a scientifically | ||
| or medically identifiable genetic or chromosomal variation, | ||
| composition, or alteration that predisposes an individual to a | ||
| disease, disorder, or syndrome. | ||
| (4) "Genetic test" means a presymptomatic laboratory | ||
| test of an individual's genes, products, or chromosomes that: | ||
| (A) analyzes the individual's DNA, RNA, | ||
| proteins, or chromosomes; and | ||
| (B) is performed to identify a genetic | ||
| characteristic. | ||
| (5) "RNA" means ribonucleic acid. | ||
| Sec. 3.002. PROPERTY RIGHT ESTABLISHED. (a) Subject to | ||
| Subsections (b) and (c), an individual has an exclusive property | ||
| right in the individual's unique DNA. A person may not, without the | ||
| informed, written consent of the individual or the individual's | ||
| legal guardian or authorized representative: | ||
| (1) collect a DNA sample from an individual; | ||
| (2) perform a genetic test on an individual's DNA | ||
| sample; | ||
| (3) retain an individual's DNA sample; | ||
| (4) alter or modify an individual's DNA; | ||
| (5) sell or otherwise transfer to another person an | ||
| individual's DNA sample; or | ||
| (6) make available or allow to be made available to | ||
| another person an individual's DNA sample. | ||
| (b) Notwithstanding Subsection (a), this chapter does not | ||
| apply: | ||
| (1) to a DNA sample collected or received for: | ||
| (A) the purpose of medical diagnosis and | ||
| treatment; | ||
| (B) the purpose of determining paternity; | ||
| (C) law enforcement purposes, including the | ||
| identification of a perpetrator, the investigation of a crime, or | ||
| the identification of a missing, unidentified, or deceased person; | ||
| (D) medical examiner purposes, including the | ||
| performance of an inquest to determine the cause or circumstance of | ||
| death under Article 49.25, Code of Criminal Procedure; | ||
| (E) research, as defined by 45 C.F.R. Section | ||
| 164.501, that is conducted in accordance with: | ||
| (i) the federal policy for the protection | ||
| of human subjects (45 C.F.R. Part 46); | ||
| (ii) the good clinical practice guidelines | ||
| issued by the International Council for Harmonisation of Technical | ||
| Requirements for Pharmaceuticals for Human Use (ICH); or | ||
| (iii) the United States Food and Drug | ||
| Administration policy for the protection of human subjects (21 | ||
| C.F.R. Parts 50 and 56); | ||
| (F) use, analysis, storage, or transfer by an | ||
| institution of higher education or a private or independent | ||
| institution of higher education, as those terms are defined by | ||
| Section 61.003, Education Code; or | ||
| (G) any other similar use under the laws of this | ||
| state or another jurisdiction; or | ||
| (2) to an entity that: | ||
| (A) is a covered entity or business associate, as | ||
| defined by 45 C.F.R. Part 160, subject to the privacy, security, and | ||
| breach notification rules under the Health Insurance Portability | ||
| and Accountability Act of 1996 (42 U.S.C. Section 1320d et seq.); | ||
| (B) offers genetic testing products or services | ||
| through a health care provider; or | ||
| (C) is a health care provider. | ||
| Sec. 3.003. CIVIL PENALTY; INJUNCTION. (a) A person who | ||
| violates Section 3.002 is liable to the state for a civil penalty | ||
| not to exceed the amount of any profits that are attributable to the | ||
| violation. The amount of profits under this subsection may be | ||
| established by showing the gross revenue attributable to the | ||
| unauthorized use minus any expenses that the person who committed | ||
| the unauthorized use may prove. | ||
| (b) Subject to Subsection (a), the amount of a civil penalty | ||
| under this section shall be based on: | ||
| (1) the seriousness of the violation, including the | ||
| nature, circumstances, extent, and gravity of the violation; | ||
| (2) the economic harm caused by the violation; | ||
| (3) the history of previous violations; | ||
| (4) the amount necessary to deter a future violation; | ||
| (5) efforts to correct the violation; and | ||
| (6) any other matter that justice may require. | ||
| (c) If it appears that a person has violated Section 3.002, | ||
| the attorney general may institute an action for a civil penalty, | ||
| injunctive relief, or both. | ||
| (d) The attorney general may recover reasonable attorney's | ||
| fees and expenses and court costs incurred in recovering a civil | ||
| penalty or obtaining injunctive relief under this section. | ||
| Sec. 3.004. CRIMINAL PENALTY. A person commits an offense | ||
| if the person, with criminal negligence, violates Section 3.002. | ||
| An offense under this section is a Class A misdemeanor. | ||
| SECTION 2. Chapter 3, Property Code, as added by this Act, | ||
| does not apply to the use or retention of a DNA sample collected or | ||
| provided before the effective date of this Act. | ||
| SECTION 3. This Act takes effect September 1, 2025. | ||
